文献速递眼底病与葡萄膜炎青光眼眼外伤

眼内手术后继发性交感性眼炎的发生率:系统综述与Meta分析

Incidence of Sympathetic Ophthalmia after Intraocular Surgery: A Systematic Review and Meta-analysis.
PubMed 文献 · Ophthalmology · 2024-01-10

该系统综述与Meta分析检索MEDLINE、EMBASE和Cochrane数据库至2023年1月1日,纳入19项基于人群的研究,共505178例诱发事件中118例发生交感性眼炎(SO)。IOS后SO总体发生比例为0.061%(95%CI 0.033%-0.111%;I²=83%),发生率为每10万人年9.24例(95%CI 4.03-21.19;I²=88%)。青光眼与玻璃体视网膜IOS后SO发生率差异无统计学意义(P=0.14),1975年前后发生率也无显著差异(P=0.98),证据确定性低。

要点

  • IOS后SO总体发生比例为0.061%(95%CI 0.033%-0.111%;I²=83%),发生率为每10万人年9.24例(95%CI 4.03-21.19;I²=88%)。
  • 青光眼IOS后SO发生比例为0.098%(95%CI 0.042%-0.232%;I²=40%),玻璃体视网膜IOS为0.043%(95%CI 0.022%-0.085%;I²=88%),差异无统计学意义(P=0.14)。
  • 1975年前后SO发生比例分别为0.060%与0.058%,差异无统计学意义(P=0.98),证据确定性低。

核心结论

  • IOS后SO罕见,且过去50年间可能未发生变化。
  • SO的估计发生比例可能有助于术前知情同意过程。
  • 基于低确定性证据,青光眼与玻璃体视网膜IOS后SO发生率可能无显著差异。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE和Cochrane数据库自建库至2023年1月1日,纳入IOS后SO的基于人群的研究。
  • 两名评价者独立筛选结果,采用随机效应Meta分析计算发生比例,并按IOS类型和技术进步进行亚组分析。
  • 最终Meta分析纳入19项研究,共505178例诱发事件中118例SO,研究平均持续时间为10.8年。
  • 采用Newcastle-Ottawa量表和GRADE框架评估研究质量与偏倚。

主要发现

  • IOS后SO总体估计发生比例为0.061%(95%CI 0.033%-0.111%;I²=83%),估计发生率为每10万人年9.24例(95%CI 4.03-21.19;I²=88%)。
  • 青光眼IOS后SO发生比例为0.098%(95%CI 0.042%-0.232%;I²=40%),玻璃体视网膜IOS为0.043%(95%CI 0.022%-0.085%;I²=88%),两者差异无统计学意义(P=0.14)。
  • 1975年现代眼内手术技术出现前后SO发生比例分别为0.060%与0.058%,差异无统计学意义(P=0.98)。
  • 结局指标显示GRADE证据确定性低。

关键数值与推荐

  • IOS后SO总体发生比例为0.061%(95%CI 0.033%-0.111%;I²=83%)。
  • IOS后SO发生率为每10万人年9.24例(95%CI 4.03-21.19;I²=88%)。
  • 青光眼IOS后SO发生比例为0.098%(95%CI 0.042%-0.232%;I²=40%),玻璃体视网膜IOS为0.043%(95%CI 0.022%-0.085%;I²=88%),差异无统计学意义(P=0.14)。
  • 1975年前后SO发生比例分别为0.060%与0.058%,差异无统计学意义(P=0.98)。
  • GRADE证据确定性低。

临床怎么用

  • SO的估计发生比例可能有助于术前知情同意过程中向医师和患者提供IOS后SO风险信息。

局限性

  • 总体发生比例分析异质性I²=83%,发生率分析异质性I²=88%。
  • 青光眼IOS亚组异质性I²=40%,玻璃体视网膜IOS亚组异质性I²=88%。
  • 结局指标显示GRADE证据确定性低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC: Sympathetic ophthalmia (SO) is a rare bilateral granulomatous panuveitis that can present after trauma or intraocular surgery (IOS). The incidence of SO after IOS varies among studies. The purpose of this review was to determine the incidence proportion of SO after IOS. CLINICAL RELEVANCE: The incidence proportion of SO after IOS can provide physicians and patients with information on the risk of SO during the consent process before surgery. METHODS: In this systematic review and meta-analysis, MEDLINE, EMBASE, and Cochrane databases were searched from inception to January 1, 2023 for population-based studies of SO after IOS. Two reviewers independently screened the results. Random-effects meta-analyses calculated incidence proportion. Subgroup analysis assessed SO incidence based on IOS type and technological advancements. Study quality and bias were assessed using the Newcastle-Ottawa scale and the Grades of Recommendation, Assessment, Development, and Evaluation framework. RESULTS: The final meta-analyses included 19 studies, with 118 cases of SO occurring after 505 178 inciting events. The estimated overall incidence proportion of SO after IOS was 0.061% (95% confidence interval [CI], 0.033%-0.111%; I2 = 83%), and the estimated incidence rate was 9.24 cases per 100 000 person-years (95% CI, 4.03-21.19; I2 = 88%). The average study duration across these studies was 10.8 years. Within the reviewed literature, SO after glaucoma and vitreoretinal IOS was studied most, with 9 and 6 studies, respectively. Observed differences in incidence between glaucoma (0.098%; 95% CI, 0.042%-0.232%; I2 = 40%) and vitreoretinal (0.043%; 95% CI, 0.022%-0.085%; I2 = 88%) IOS were not statistically significant (P = 0.14). Also, no significant difference was found in the incidence proportion before and after 1975, when modern intraocular surgical techniques emerged (0.060% vs. 0.058%; P = 0.98). The outcome measures showed low-certainty Grades of Recommendation, Assessment, Development, and Evaluation evidence. DISCUSSION: Sympathetic ophthalmia after IOS is rare and might not have changed over the past 5 decades. The estimated incidence proportion of SO may be useful during the consent process before surgery. Also, no significant difference may exist in the incidence of SO between glaucoma and vitreoretinal IOS, based on low-certainty evidence. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Bondok MS, He B, Ka-Lok Tao B, et al. Incidence of Sympathetic Ophthalmia after Intraocular Surgery: A Systematic Review and Meta-analysis. Ophthalmology. 2024. PMID: 38215990. doi:10.1016/j.ophtha.2024.01.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。